• Charles River rolled out an automated manufacturing suite for Endosafe endotoxin testing cartridges, expanding inspection, traceability, controls, capacity.
• Full operational capacity targeted for Q3 2026; suite became fully operational in July 2026.
• Reported 14% capacity increase across Trillium and LAL cartridges; labor productivity rose 87% versus manual production.
• Scrap rate fell 2%; invalid cartridge rate dropped 13%, supporting tighter quality consistency.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260908778943) on September 08, 2026, and is solely responsible for the information contained therein.